The discovery of penicillin is one of the most widely known and frequently discussed scientific events of the twentieth century. Fleming\'s original discovery, as well as the work of both the Oxford team who isolated the drug, and the American pharmaceutical companies who developed mass manufacturing methods have together already generated a large---and sometimes controversial---literature. Most of the accounts, however, have been devoted to the early years and the story of discovery and development. In this book, the fruit of many years of research and scholarship, Bud explores the story of penicillin over a sixty-year period in a much wider social, cultural and geographical context. He accompanies his analysis of the "triumph", the conquering of infection, with what he terms the "tragedy", the excessive use of penicillin which has led directly to the growth and spread of bacteria resistant to antibiotics.

The first four chapters cover the pre-penicillin era, the discovery and development of penicillin and its creation as a "brand", the analogy or model Bud has chosen to use for penicillin and its family of antibiotic drugs. By doing this he separates the drugs themselves and their chemical composition from the concept of the brand; this means that the brand encompasses the stories, legion and legendary, which shaped the perception of penicillin as a wonder drug, carrying with it a heavy burden of expectation of an infection-free future.

Chapter 5 charts the very rapid growth in the prescription and consumption of penicillin in the 1950s, the decade in which most of the penicillin formulations, unpatented, were manufactured across the world and the price dropped to commodity levels. At the same time the new broad spectrum antibiotics were discovered, developed, patented and marketed at prices which provided the pharmaceutical corporations with the monopoly profits they required to fund not only the growth of large institutional R&D laboratories, but also large sales forces and international expansion. Although the costs of the new drugs marketed in the post-war period were high (and there were other new products such as cortisone, as well as the antibiotics) it is arguable whether Bud gives too much significance to the role of penicillin in attributing the fall of the Labour government solely to its cost to the NHS (p. 111). He is on firmer ground in noting that, even in the early days, the signs of drug resistance began to emerge, with the first cases of what is now called the "super bug", MRSA, in the 1960s; these are explored, together with the development of the semi-synthetic penicillins, in chapter 6.

A brand can be diluted or damaged very quickly by loss of trust, and Bud discusses this at some length in chapter 7, when he explores the complex transaction by which prescription medicine reaches its ultimate consumer, and the relationships between doctors and patients. He goes on to examine the use of penicillin in animals through the second half of the twentieth century in chapter 8. The penultimate chapter discusses the threat of a "post-antibiotic" age in the light of the emergence of not only drug-resistant bacteria but also of new diseases such as AIDS in humans and BSE in animals, reflecting on the changing perceptions of the penicillin brand and use of antibiotics. These developments, together with other changes in the last two decades of the twentieth century, such as the emergence of biotechnology and increasing scientific knowledge lead to a concluding chapter which argues that while penicillin is no longer a "wonder drug", it is, and is likely to continue to be, useful.

This is an erudite and wide-ranging study of a revolutionary drug, offering much of interest to historians of medicine, of science and of business. It also deserves to reach a wider non-academic audience interested in a scientific revolution which shaped our lives in the second half of the twentieth century.
